Clinical trial
The Relation Between Plasma Irisin Level and Endothelial Dysfunction in Type 2 Diabetes
NCT01877603 is registered in ClinicalTrials.gov with Wuhan General Hospital of Guangzhou Military Command as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Relation Between Plasma Irisin Level and Endothelial Dysfunction in Type 2 Diabetes
- Lead sponsor
- Wuhan General Hospital of Guangzhou Military Command
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2013
- Completion date
- December 31, 2013
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endothelial dysfunction, irisin, type 2 diabetes